Filing Details

Accession Number:
0001179110-10-012028
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-07-30 13:00:00
Reporting Period:
2010-07-28
Filing Date:
2010-07-30
Accepted Time:
2010-07-30 16:51:42
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1142596 Nuvasive Inc NUVA Surgical & Medical Instruments & Apparatus (3841) 330768598
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1345767 P Jeffrey Rydin 7475 Lusk Blvd.
San Diego CA 92121
Evp, Sales, Americas No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2010-07-28 3,000 $23.24 3,713 No 4 M Direct
Common Stock Disposition 2010-07-28 3,000 $36.25 713 No 4 S Direct
Common Stock Acquisiton 2010-07-28 4,069 $17.91 4,782 No 4 M Direct
Common Stock Disposition 2010-07-28 4,069 $36.25 713 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2010-07-28 3,000 $0.00 3,000 $23.24
Common Stock Stock Option (Right to Buy) Disposition 2010-07-28 4,069 $0.00 4,069 $17.91
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
52,067 2017-01-16 No 4 M Direct
0 2009-12-05 2015-12-05 No 4 M Direct
Footnotes
  1. The shares sold were acquired contemporaneously upon the cashless exercise of a stock option at an exercise price of $23.24 per share.
  2. The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 13,2009.
  3. Includes the sale of 640 shares on May 26, 2010 and 1,274 shares on July 28, 2010 by the Reporting Person that were acquired through the Issuer's Employee Stock Purchase Plan. Both the purchase and subsequent sale of these shares are exempt from reporting under Section 16b-3.
  4. The shares sold were acquired contemporaneously upon the cashless exercise of a stock option at an exercise price of $17.91 per share.
  5. 25% of the total shares subject to the option vested on January 16, 2008 which was the first anniversary of the date of the grant; the remaining shares vest in 36 equal monthly installments thereafter.